The Boards of Directors of two Breximco Group companies have released unaudited financial reports for the first quarter of the current financial year (July-September, 2024). The two companies are Beximco Limited and Beximco Pharmaceuticals Limited.

This information was informed by Dhaka and Chittagong Stock Exchange (DSE-CSE) sources on Thursday.

The dividend decision was taken after reviewing and approving the last year’s audited financial reports in the board meeting of the two companies held on Wednesday.

Beximco: In the first quarter of the current financial year, the company posted a loss per share of tk (1.26). The company had a loss per share of tk (0.79) in the corresponding period of the previous financial year. As a result, the loss per share (EPS) of the company increased. As on September 30, 2024, the company’s net asset value per share (NAVPS) stood at Tk 89.44.

Beximco Pharmaceuticals: The company’s profit per share in the first quarter of the current financial year has been Tk 3.77. The company’s profit per share was Tk 3.48 in the corresponding period of the previous financial year. As a result, the company’s earnings per share (EPS) increased. As on September 30, 2024, the company’s net asset value per share (NAVPS) stood at Tk 111.25.